Birdwatch Archive

Birdwatch Note

2023-10-19 20:57:12 UTC - NOT_MISLEADING

SV40 has indeed been implicated in cancer development in various tissues in animals. Human malignancies also contain SV40 markers ‘It is noteworthy that SV40 has been detected in malignancies from children and young adults’ https://tlcr.amegroups.org/article/view/35999/24352 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC452549/

Written by 5C2D01CF9573EDBDE494337CC00B26EDB629E78D8DB9024D31E8EAD8D276AEF0
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1715024662449533375

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1715109867671712014
  • noteId - 1715109867671712014
  • participantId -
  • noteAuthorParticipantId - 5C2D01CF9573EDBDE494337CC00B26EDB629E78D8DB9024D31E8EAD8D276AEF0 Participant Details
  • createdAtMillis - 1697749032309
  • tweetId - 1715024662449533375
  • classification - NOT_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 0
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 0
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 1
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • SV40 has indeed been implicated in cancer development in various tissues in animals. Human malignancies also contain SV40 markers ‘It is noteworthy that SV40 has been detected in malignancies from children and young adults’ https://tlcr.amegroups.org/article/view/35999/24352 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC452549/

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-10-19 20:57:12 UTC
(1697749032309)
1969-12-31 23:59:59 UTC
(-1)
2023-10-20 06:10:01 UTC
(1697782201371)
NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)

Note Ratings

rated at rated by
2023-10-19 19:06:32 -0500 Rating Details
2023-10-19 18:54:50 -0500 Rating Details
2023-10-19 18:52:31 -0500 Rating Details
2023-10-19 18:18:35 -0500 Rating Details
2023-10-19 18:04:25 -0500 Rating Details
2023-10-19 17:55:26 -0500 Rating Details
2023-10-19 17:42:01 -0500 Rating Details
2023-10-19 17:14:31 -0500 Rating Details
2023-10-19 17:01:29 -0500 Rating Details
2023-10-19 16:59:33 -0500 Rating Details
2023-10-19 16:45:31 -0500 Rating Details
2023-10-19 16:35:10 -0500 Rating Details
2023-10-19 16:30:26 -0500 Rating Details
2023-10-19 16:30:03 -0500 Rating Details
2023-10-19 16:25:26 -0500 Rating Details
2023-10-19 16:17:31 -0500 Rating Details
2023-10-20 19:01:49 -0500 Rating Details
2023-10-20 18:10:30 -0500 Rating Details
2023-10-20 14:32:57 -0500 Rating Details
2023-10-20 08:51:03 -0500 Rating Details
2023-10-20 07:36:55 -0500 Rating Details
2023-10-20 07:19:50 -0500 Rating Details
2023-10-20 05:31:49 -0500 Rating Details
2023-10-20 01:18:37 -0500 Rating Details
2023-10-20 01:11:33 -0500 Rating Details
2023-10-20 00:24:29 -0500 Rating Details
2023-10-19 23:45:07 -0500 Rating Details
2023-10-19 23:17:08 -0500 Rating Details
2023-10-19 22:07:18 -0500 Rating Details
2023-10-19 22:05:12 -0500 Rating Details
2023-10-19 21:31:24 -0500 Rating Details
2023-10-19 20:38:13 -0500 Rating Details
2023-10-19 20:09:11 -0500 Rating Details
2023-10-21 14:04:50 -0500 Rating Details
2023-10-23 10:34:07 -0500 Rating Details
2023-10-23 09:40:32 -0500 Rating Details
2023-10-23 04:49:02 -0500 Rating Details
2023-10-24 11:17:36 -0500 Rating Details
2023-10-28 17:20:38 -0500 Rating Details
2023-10-25 11:45:14 -0500 Rating Details
2023-10-21 08:35:25 -0500 Rating Details
2023-10-20 19:31:59 -0500 Rating Details
2023-10-20 18:46:08 -0500 Rating Details
2023-10-20 16:40:54 -0500 Rating Details
2023-10-20 16:36:50 -0500 Rating Details
2023-10-20 15:52:03 -0500 Rating Details
2023-10-20 14:12:00 -0500 Rating Details
2023-10-20 12:04:52 -0500 Rating Details
2023-10-20 11:05:10 -0500 Rating Details
2023-10-20 10:08:20 -0500 Rating Details
2023-10-20 10:03:24 -0500 Rating Details
2023-10-20 09:58:35 -0500 Rating Details
2023-10-20 09:46:49 -0500 Rating Details
2023-10-20 07:38:56 -0500 Rating Details
2023-10-20 07:19:53 -0500 Rating Details
2023-10-20 06:34:33 -0500 Rating Details
2023-10-20 05:40:02 -0500 Rating Details
2023-10-20 03:24:06 -0500 Rating Details
2023-10-20 01:33:56 -0500 Rating Details
2023-10-20 01:32:34 -0500 Rating Details
2023-10-20 01:26:06 -0500 Rating Details
2023-10-20 01:23:22 -0500 Rating Details
2023-10-20 00:08:02 -0500 Rating Details
2023-10-20 00:06:29 -0500 Rating Details
2023-10-19 23:45:46 -0500 Rating Details
2023-10-19 23:18:49 -0500 Rating Details
2023-10-19 23:16:23 -0500 Rating Details
2023-10-19 22:37:42 -0500 Rating Details
2023-10-19 22:25:56 -0500 Rating Details
2023-10-19 22:21:01 -0500 Rating Details
2023-10-19 22:16:44 -0500 Rating Details
2023-10-19 21:41:17 -0500 Rating Details
2023-10-19 21:12:58 -0500 Rating Details
2023-10-19 21:01:14 -0500 Rating Details
2023-10-19 20:52:32 -0500 Rating Details
2023-10-19 20:01:32 -0500 Rating Details
2023-10-19 18:42:13 -0500 Rating Details
2023-10-19 17:57:19 -0500 Rating Details
2023-10-19 17:35:36 -0500 Rating Details
2023-10-19 17:00:39 -0500 Rating Details
2023-10-19 16:43:30 -0500 Rating Details
2023-10-19 16:28:50 -0500 Rating Details
2023-10-19 16:12:51 -0500 Rating Details
2024-01-30 23:42:12 -0600 Rating Details
2024-03-19 11:45:22 -0500 Rating Details
2024-03-23 21:50:47 -0500 Rating Details
2024-04-08 11:41:41 -0500 Rating Details
2024-04-08 06:35:32 -0500 Rating Details